Syngene International Limited (SYNGENE): research summary

Price history, fundamentals, business-quality scores, DCF intrinsic value, shareholding, quarterly results and risk metrics for Syngene International Limited, explained in plain English.

• ▪Syngene International Limited is tracked in the Pharma & Healthcare sector of the NSE universe covered here.
• ▪SYNGENE closed at ₹398.60 on 29 October 2026.
• ▪Over the past year the shares are down 39.5%, trading between ₹344.45 and ₹678.95.
• ▪Reported fundamentals show return on equity of 3.88%, a net margin of 5.28%, debt to equity of 10.44.
• ▪Our transparent MaxGrade checklist scores it D (41/100) across momentum, growth, profitability and safety, using Pharma & Healthcare sector medians as the bar.
• ▪Annualised volatility over the past year is 35.74% with a maximum drawdown of -47.88% and a beta of 0.71 against NIFTY 50.
• ▪Recent coverage: Syngene International shares surge 12%, biggest 1-day gain in 6 years; what drove the rally despite a Q2 profit drop?

Other Pharma & Healthcare companies: Abbott India, Acutaas Chemicals, Ajanta Pharmaceuticals, Alkem Laboratories, Anthem Biosciences, Apollo Hospitals Enterprise, Aster DM Quality Care, Aurobindo Pharma

Last traded values from 29 Oct 2026. Market opens at 9:15 IST.